Loading stock data...

Amrutanjan Health Care Limited

NSE: AMRUTANJAN BSE: AMRUTANJAN

NSE
719.80 -11.25 (-1.54%)

Prev Close

731.05

Open Price

734.95

Volume

16,238

Today Low / High

717 / 735

52 WK Low / High

544.1 / 862.6

Range

684 - 756

BSE
720.45 -8.05 (-1.11%)

Prev Close

728.5

Open Price

732.1

Volume

2,294

Today Low / High

717 / 732.25

52 WK Low / High

548.05 / 861.4

Range

684 - 756

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 719.8 (target range: 684 - 756), reflecting a change of -11.25 (-1.53888%). On the BSE, it is listed at 720.45 (target range: 684 - 756), showing a change of -8.05 (-1.10501%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

30 Jun 734.95 -2.06%
27 Jun 724.40 0.92%
26 Jun 732.00 -0.28%
25 Jun 721.00 1.55%
24 Jun 730.55 -1.41%
23 Jun 727.85 0.32%
20 Jun 715.10 1.78%
19 Jun 722.90 0.48%
18 Jun 702.20 2.31%
17 Jun 704.15 0.49%
16 Jun 688.55 1.50%
13 Jun 691.00 0.64%
12 Jun 697.00 0.51%
11 Jun 707.20 -1.03%
10 Jun 712.25 -0.71%
09 Jun 719.85 -1.06%
06 Jun 722.50 -1.11%
05 Jun 738.00 -2.10%
04 Jun 734.40 -0.37%
03 Jun 726.00 0.39%
02 Jun 707.70 2.47%

Amrutanjan Health Care Limited Graph

Amrutanjan Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Amrutanjan Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 719.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 720.45 727.65 654.89 - 800.42
734.86 587.89 - 881.83
742.06 519.44 - 964.68
Bearish Scenario 720.45 713.25 641.92 - 784.57
706.04 564.83 - 847.25
698.84 489.19 - 908.49

Overview of Amrutanjan Health Care Limited

ISIN

INE098F01031

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

27,271

Market Cap

21,040,185,880

Last Dividend

4.6

Official Website

Visit Website

IPO Date

2009-11-05

DCF Diff

266.85

DCF

453

Financial Ratios Every Investor Needs

Stock Dividend of AMRUTANJAN

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-02-18 February 18, 25 1 1 2025-02-18 2025-03-14
2024-11-22 November 22, 24 1 1 2024-11-22 2024-12-12
2024-09-13 September 13, 24 2.6 2.6 2024-09-16 2024-10-23
2024-02-20 February 20, 24 1 1 2024-02-20 2024-03-10
2023-11-23 November 23, 23 1 1 2023-11-23 2023-12-10

Stock Rating Details for AMRUTANJAN

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 469.50 Cr 223.21 Cr 246.29 Cr 0.5246 0.00 Cr 59.10 Cr 131.07 Cr 50.83 Cr 17.58 75.88 Cr 0.1083
2024-03-31 421.23 Cr 211.83 Cr 209.40 Cr 0.4971 0.00 Cr 26.27 Cr 62.10 Cr 44.97 Cr 15.50 68.16 Cr 0.1068
2023-03-31 379.54 Cr 181.98 Cr 197.56 Cr 0.5205 1.20 Cr 4.46 Cr 41.85 Cr 39.83 Cr 13.65 59.08 Cr 0.1050
2022-03-31 405.45 Cr 180.46 Cr 224.98 Cr 0.5549 1.13 Cr 2.73 Cr 79.84 Cr 67.19 Cr 23.00 94.70 Cr 0.1657
2021-03-31 331.55 Cr 140.19 Cr 191.36 Cr 0.5772 0.87 Cr 2.44 Cr 71.79 Cr 61.19 Cr 20.94 86.17 Cr 0.1846

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 83.16 Cr 421.39 Cr 94.77 Cr 326.6146 Cr 2.08 Cr -81.08 Cr 27.26 Cr 63.93 Cr 0.00 Cr 0.00 Cr 0.05 Cr 84.5832 Cr
2024-03-31 25.76 Cr 366.87 Cr 78.38 Cr 288.4883 Cr 1.73 Cr -24.04 Cr 28.90 Cr 49.54 Cr 1.06 Cr 0.00 Cr 11.55 Cr 69.9185 Cr
2023-03-31 4.90 Cr 362.09 Cr 71.32 Cr 290.7719 Cr 0.91 Cr -3.99 Cr 28.83 Cr 47.55 Cr 7.22 Cr -1.77 Cr 43.05 Cr 63.0121 Cr
2022-03-31 83.48 Cr 349.87 Cr 84.74 Cr 265.1238 Cr 0.88 Cr -82.60 Cr 26.00 Cr 43.47 Cr 9.95 Cr -1.70 Cr 22.31 Cr 77.4730 Cr
2021-03-31 130.70 Cr 274.27 Cr 58.71 Cr 215.5647 Cr 1.34 Cr -129.36 Cr 17.46 Cr 23.32 Cr 5.94 Cr -1.80 Cr 20.60 Cr 52.1034 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 50.8992 Cr -30.9664 Cr -13.4896 Cr 15.3463 Cr 6.4432 Cr 10.1552 Cr -35.5529 Cr 50.8347 Cr -0.4609 Cr -13.2665 Cr 1.6449 Cr
2024-03-31 27.9106 Cr 19.1650 Cr -48.2664 Cr 21.1929 Cr -1.1908 Cr 3.7120 Cr -6.7177 Cr 44.9726 Cr 0.0000 Cr -13.3863 Cr -0.0796 Cr
2023-03-31 19.2181 Cr -2.4750 Cr -14.0265 Cr 10.2914 Cr 2.7166 Cr 4.9028 Cr -8.9267 Cr 53.6454 Cr 0.0000 Cr -14.4091 Cr -2.8244 Cr
2022-03-31 52.1956 Cr -36.2119 Cr -16.7024 Cr 28.7322 Cr -0.7189 Cr 2.1862 Cr -23.4634 Cr 90.5766 Cr 0.0000 Cr -12.4765 Cr -8.5421 Cr
2021-03-31 89.7629 Cr -87.7608 Cr -6.3167 Cr 87.8022 Cr -4.3155 Cr 2.9051 Cr -1.9607 Cr 81.9045 Cr 0.0000 Cr -4.6770 Cr 6.2573 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 140.23 Cr 68.99 Cr 71.24 Cr 0.5080 39.34 Cr 15.18 Cr 5.25 22.53 Cr 0.1082
2024-12-31 122.75 Cr 55.80 Cr 66.95 Cr 0.5454 21.68 Cr 19.25 Cr 6.66 27.71 Cr 0.1568
2024-09-30 109.92 Cr 54.41 Cr 55.51 Cr 0.5050 11.95 Cr 11.80 Cr 4.08 17.65 Cr 0.1073
2024-06-30 83.74 Cr 59.45 Cr 24.28 Cr 0.2900 1.96 Cr 4.62 Cr 1.60 8.00 Cr 0.0551
2024-03-31 100.22 Cr 51.10 Cr 49.12 Cr 0.4901 11.57 Cr 13.66 Cr 4.35 16.24 Cr 0.1363

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 83.16 Cr 0.00 Cr 83.16 Cr 55.82 Cr 27.26 Cr 290.67 Cr 63.93 Cr 421.39 Cr 94.77 Cr
2024-12-31 0.00 Cr 0.00 Cr 229.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -297.79 Cr
2024-09-30 7.07 Cr 222.30 Cr 229.37 Cr 0.00 Cr 32.63 Cr 305.60 Cr 49.14 Cr 382.60 Cr 84.81 Cr
2024-06-30 0.00 Cr 0.00 Cr 211.31 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -288.49 Cr
2024-03-31 25.76 Cr 0.00 Cr 211.31 Cr 0.00 Cr 28.90 Cr 295.68 Cr 49.54 Cr 366.87 Cr 78.38 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 15.18 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 19.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 11.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 4.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 13.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2018-04-13 April 13, 18 2:1
2012-10-25 October 25, 12 5:1

Similar Stocks: Drug Manufacturers - Specialty & Generic

Company Name Symbol Price Market Cap Volume
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,675.70 ₹4,020,473,496,000.00 ₹2,160,156.00
Divi's Laboratories Limited DIVISLAB ₹6,809.50 ₹1,807,711,155,500.00 ₹599,616.00
Torrent Pharmaceuticals Limited TORNTPHARM ₹3,408.20 ₹1,153,488,249,000.00 ₹2,210,812.00
Dr. Reddy's Laboratories Limited DRREDDY ₹1,283.30 ₹1,067,807,930,342.00 ₹2,224,032.00
Zydus Lifesciences Limited ZYDUSLIFE ₹989.95 ₹996,117,388,500.00 ₹818,641.00
Mankind Pharma Limited MANKIND ₹2,319.80 ₹957,448,177,448.00 ₹242,516.00
Lupin Limited LUPIN ₹1,938.00 ₹885,074,910,000.00 ₹747,405.00
Aurobindo Pharma Limited AUROPHARMA ₹1,134.80 ₹659,094,109,600.00 ₹1,653,538.00
Alkem Laboratories Limited ALKEM ₹4,939.00 ₹590,531,535,000.00 ₹71,581.00
Glenmark Pharmaceuticals Limited GLENMARK ₹1,753.80 ₹494,924,113,800.00 ₹925,570.00
Suven Pharmaceuticals Limited SUVENPHAR ₹1,078.00 ₹412,407,234,624.00 ₹1,177,218.00
Laurus Labs Limited LAURUSLABS ₹724.85 ₹390,877,537,050.00 ₹4,837,288.00
Cohance Lifesciences Limited COHANCE ₹967.90 ₹370,286,607,043.00 ₹533,262.00
Ipca Laboratories Limited IPCALAB ₹1,389.80 ₹352,597,819,200.00 ₹334,888.00
Ajanta Pharma Limited AJANTPHARM ₹2,574.10 ₹321,535,979,200.00 ₹131,475.00
Wockhardt Limited WOCKPHARMA ₹1,714.00 ₹278,489,006,000.00 ₹1,320,711.00
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM ₹1,679.30 ₹262,069,878,700.00 ₹1,260,647.00
Piramal Enterprises Limited PEL ₹1,144.20 ₹259,364,967,600.00 ₹439,580.00
Eris Lifesciences Limited ERIS ₹1,683.80 ₹229,328,508,600.00 ₹146,873.00
AstraZeneca Pharma India Limited ASTRAZEN ₹8,908.50 ₹222,712,500,000.00 ₹41,092.00
Alembic Pharmaceuticals Limited APLLTD ₹1,039.10 ₹204,248,613,300.00 ₹15,274,048.00
Jubilant Pharmova Limited JUBLPHARMA ₹1,210.60 ₹192,825,578,600.00 ₹542,905.00
NATCO Pharma Limited NATCOPHARM ₹926.65 ₹165,972,281,500.00 ₹2,317,809.00
Caplin Point Laboratories Limited CAPLIPOINT ₹2,117.60 ₹160,962,375,920.00 ₹209,291.00
Neuland Laboratories Limited NEULANDLAB ₹12,000.00 ₹153,958,800,000.00 ₹31,199.00
Glenmark Life Sciences Limited GLS ₹1,086.00 ₹133,070,838,000.00 ₹130,938.00
Granules India Limited GRANULES ₹495.30 ₹120,181,573,200.00 ₹480,052.00
Procter & Gamble Health Limited PGHL ₹5,880.50 ₹97,612,771,700.00 ₹5,473.00
Shilpa Medicare Limited SHILPAMED ₹890.55 ₹87,087,685,995.00 ₹84,311.00
Strides Pharma Science Limited STAR ₹899.65 ₹82,914,173,055.00 ₹451,712.00
Aarti Pharmalabs Limited AARTIPHARM ₹890.35 ₹80,696,533,917.00 ₹509,474.00
FDC Limited FDC ₹487.50 ₹79,369,875,000.00 ₹123,391.00
Suven Life Sciences Limited SUVEN ₹246.15 ₹53,678,915,100.00 ₹185,211.00
Sun Pharma Advanced Research Company Limited SPARC ₹162.39 ₹52,699,127,580.00 ₹588,486.00
Innova Captab Limited INNOVACAP ₹858.75 ₹49,141,908,638.00 ₹33,627.00
Sequent Scientific Limited SEQUENT ₹192.75 ₹48,246,288,750.00 ₹444,510.00
Hikal Limited HIKAL ₹358.90 ₹44,252,728,900.00 ₹296,200.00
Aarti Drugs Limited AARTIDRUGS ₹458.15 ₹41,815,350,500.00 ₹289,887.00
Unichem Laboratories Limited UNICHEMLAB ₹589.30 ₹41,490,137,940.00 ₹13,357.00
RPG Life Sciences Limited RPGLIFE ₹2,480.80 ₹41,029,951,200.00 ₹30,790.00
Gufic Biosciences Limited GUFICBIO ₹364.05 ₹36,506,205,900.00 ₹138,450.00
Orchid Pharma Limited ORCHPHARMA ₹714.30 ₹36,228,653,130.00 ₹50,530.00
Morepen Laboratories Limited MOREPENLAB ₹61.77 ₹33,847,118,580.00 ₹4,023,013.00
Alembic Limited ALEMBICLTD ₹121.80 ₹31,276,047,478.00 ₹6,054,805.00
Solara Active Pharma Sciences Limited SOLARA ₹637.05 ₹30,675,868,650.00 ₹262,587.00
Indoco Remedies Limited INDOCO ₹317.60 ₹29,297,933,040.00 ₹135,261.00
IOL Chemicals and Pharmaceuticals Limited IOLCP ₹97.19 ₹28,527,889,130.00 ₹1,241,703.00

Key Executives

Chief Sales Officer
R. Narayanan

Gender: Not Specified

Year Born:

Chief Financial Officer
Mr. N. Swaminathan

Gender: male

Year Born:

Executive Chairman & MD
Mr. Sambhu Prasad Sivalenka

Gender: male

Year Born: 1974

Chief Marketing Officer
Mani Bhagavatheeswaran

Gender: Not Specified

Year Born:

Chief Operating Officer of Supply Chain & Product Delivery
Mr. S. Jeyakanth

Gender: male

Year Born:

Compliance Officer & Company Secretary
Mr. Mahalingam Srinivasan

Gender: male

Year Born:

FAQs about Amrutanjan Health Care Limited

Who is the CEO of the company?

The CEO is Sambhu Prasad Sivalenka.

What is the current market price of the stock?

The current price is ₹719.80.

What is the 52-week price range?

The range is ₹544.1-862.6.

What is the market capitalization of the company?

The market capitalization is ₹2,104.02 crores.

What is the dividend yield?

The dividend yield is 0.64%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 40.94.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Amrutanjan Health Care Limited (ISIN: INE098F01031) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹2,104.02 crores and an average daily volume of 27,271 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹4.6.